ArticleJournal of hepatocellular carcinoma2026

A Retrospective Study of Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Hepatocellular Carcinoma Patients with Main Portal Vein Tumor Thrombus (VP4).

Xiaolong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.